Application of transient elastography in nonalcoholic fatty liver disease
FibroScan - Because liver health matters
JKMS :: Journal of Korean Medical Science
Non-invasive tests of non-alcoholic fatty liver disease | Chinese Medical Journal
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice
PDF) Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan
How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis? | SpringerLink
Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discrimination | Scientific Reports
Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes - Kuchay - 2021 - JGH Open - Wiley Online Library
Frontiers | Validation of Controlled Attenuation Parameter Measured by FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic Derangement
Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan
körülvesz Remeg tanterv kwok nash fibroscan cap Általában véve ajándék klub
How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis? | SpringerLink
Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery | Scientific Reports
PDF) Estimation of Liver Fat by FibroScan in Patients With Nonalcoholic Fatty Liver Disease
Evaluation of metabolic dysfunction-associated fatty liver disease using FibroScan, diet, and microbiota: A large cross-sectional study | PLOS ONE
Diagnostics | Free Full-Text | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan
A prospective 5-year study on the use of transient elastography to monitor the improvement of non-alcoholic fatty liver disease following bariatric surgery | Scientific Reports
Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD
Frontiers | Liver Steatosis: Better Predictor of CKD in MAFLD Than Liver Fibrosis as Determined by Transient Elastography With Controlled Attenuation Parameter
FibroScan - Because liver health matters
körülvesz Remeg tanterv kwok nash fibroscan cap Általában véve ajándék klub
Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine
körülvesz Remeg tanterv kwok nash fibroscan cap Általában véve ajándék klub
FibroScan - Because liver health matters
Application of transient elastography in nonalcoholic fatty liver disease
